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Over-expression of a retinol 
dehydrogenase (SRP35/DHRS7C) in 
skeletal muscle activates mTORC2, 
enhances glucose metabolism and 
muscle performance
Alexis Ruiz1, Erez Dror2, Christoph Handschin  3, Regula Furrer3, Joaquin Perez-Schindler3, 
Christoph Bachmann1, Susan Treves1,4 & Francesco Zorzato1,4
SRP-35 is a short-chain dehydrogenase/reductase belonging to the DHRS7C dehydrogenase/ reductase 
family 7. Here we show that its over-expression in mouse skeletal muscles induces enhanced muscle 
performance in vivo, which is not related to alterations in excitation-contraction coupling but rather 
linked to enhanced glucose metabolism. Over-expression of SRP-35 causes increased phosphorylation 
of AktS473, triggering plasmalemmal targeting of GLUT4 and higher glucose uptake into muscles. SRP-35 
signaling involves RARα and RARγ (non-genomic effect), PI3K and mTORC2. We also demonstrate that 
all-trans retinoic acid, a downstream product of the enzymatic activity of SRP-35, mimics the effect of 
SRP-35 in skeletal muscle, inducing a synergistic effect with insulin on AKTS473 phosphorylation. These 
results indicate that SRP-35 affects skeletal muscle metabolism and may represent an important target 
for the treatment of metabolic diseases.
Skeletal muscle is the largest body organ comprising approximately 40% of total body weight under normal 
conditions, it is not only important for movement and posture but also for metabolism and thermogenesis1,2. 
Furthermore, skeletal muscle adapts to different environmental conditions and load requirements by modifying 
its fiber type composition and glycolytic or oxidative characteristics3,4. Muscle fiber type composition is deter-
mined mainly by the expression of specific myosin heavy chain isoforms: MyHC I in slow fibres, MyHC type IIa 
in fast oxidative fibres and MyHC IIx/b in fast glycolytic fibres4,5. The differences in contractile properties between 
slow and fast fibers also depends on the higher density of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), 
expression of Ca2+- binding proteins such as parvalbumin, calsequestrin 1 and calsequestrin 2, and a higher 
mitochondrial content in slow type I fibers compared to fast type II fibers4,6,7.
Skeletal muscle is responsible for 70–75% of the insulin stimulated glucose uptake;8 part of the energy 
obtained from glucose is used to fuel muscles and the remaining is stored as glycogen9. Two glucose transporters 
are expressed in skeletal muscle: GLUT4 and GLUT1 which are insulin-sensitive and insulin-insensitive, respec-
tively10–12. Insulin receptor stimulation activates a number of downstream signaling proteins including phospho-
inositide 3-kinase (PI3K) and protein kinase B (PKB or Akt) which induce GLUT4 translocation to the plasma 
membrane where it facilitates blood glucose clearance and glucose uptake into muscles9,13.
In the past years our laboratory has discovered novel proteins of the skeletal muscle sarcoplasmic reticu-
lum (SR)14. One such protein we identified at the molecular level is SRP-35, a 35 kDa membrane bound protein 
enriched in sarcotubular membranes. The NH2-terminus of SR-P35 encompasses a short hydrophobic sequence 
associated to SR membranes, whereas its C-terminal domain faces the myoplasm. Sequence comparison and 
functional in vitro experiments established that SRP-35 is a short-chain dehydrogenase/ reductase belonging 
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to the DHRS7C [dehydrogenase/reductase (short-chain dehydrogenase/reductase family) member 7C] subfam-
ily15,16, using retinol (Vit. A) as its substrate and leading to the formation of all-trans-retinaldehyde17. The latter 
is the substrate for an irreversible oxidative reaction generating all- trans retinoic acid (atRA). Retinoic acid 
(RA) acts as a ligand for the family of nuclear retinoic acid receptors (RAR) and nuclear retinoid X receptors 
(RXR), encoded by separate genes for the three subtypes, α, β and γ of both RAR and RXR in mammalian cells18. 
Nuclear retinoic acid receptors regulate the expression of genes involved in a variety of biological processes rang-
ing from tissue development to cell differentiation19. In addition, RA and its nuclear receptors exert non-genomic 
extra-nuclear activity, further extending the spectrum of effects of RA on biological functions20. Indeed, in the 
past few years a number of studies have revealed that RA influences cell metabolism21,22, by modulating, the (i) 
phosphorylation state of AMPK and Akt23 and (ii) rate of glucose uptake by L6 myotubes24.
Because of the important metabolic role of RA, we generated a transgenic mouse line overexpressing SRP-35 
in skeletal muscle. Our results show that these transgenic mice (SRP35TG) exhibit enhanced running capacity, 
enhanced glucose uptake leading to larger glycogen stores. Furthermore, the presence of the transgene induces 
a stronger activation of PI3K and of mammalian target of rapamycin complex 2 (mTORC2) signaling pathways, 
triggering the phosphorylation of AktS473, which promote GLUT4 translocation onto the plasma membrane. The 
metabolic changes observed in SRP35TG mice could be mimicked by treating skeletal muscles of wild type mice 
with atRA.
Results
Impact of SRP-35 over-expression on the expression of SR ECC proteins and on muscle func-
tion. We generated TG mice encoding mouse SRP-35 under the skeletal muscle specific creatine kinase pro-
moter (Supplementary Fig. 1A). The presence of the transgene was confirmed by polymerase chain reaction 
(PCR) (Supplementary Fig. 1B), Coomassie Blue staining on a total SR extract of skeletal muscle from WT 
and SRP35TG mice (Supplementary Fig. 1C asterisk) and Western blotting. We obtained three mouse lines 
expressing the TG to different extents: line 4, 5 and 6 over-expressing SRP-35 by 28%, 61% and 23%, respec-
tively (Supplementary Fig. 1D). In this study, we performed most of the experiments on muscles from line 5 
and their respective wild-type (WT) littermates but similar results were obtained on the other TG lines. We first 
investigated in vivo and in vitro muscle function using the voluntary running wheel and electrically stimulated 
force generation, respectively. Figure 1 shows that after 21 days young (7 months, Fig. 1A left panel) and old 
(14 months, Fig. 1A right panel) SRP35TG male mice (closed circles) ran approximately 50 Km more (n = 16 
p < 0.001, Mann-Whitney test) compared to their age matched WT littermates (Fig. 1A, open circles). The higher 
running capacity of the SRP35TG mice between day 15 and day 20 is also paralleled by a remarkable increase 
in the number of 10 s high speed events (>2.5 km/hr) occurring during the dark phase (Fig. 1B). The enhanced 
running capacity is not linked to changes in fiber type composition since we found an equal distribution of MyHC 
I and MyHC II positive fibers in extensor digitorum longus (EDL) and soleus muscles in WT and SRP35TG mice 
(Fig. 1C). However, over-expression of SRP-35 caused a small (10%) but significant (p < 0.05 Student’s t test) 
increase of the minimal Feret’s diameter of MyHC type I and MyHC type II fibers (Fig. 1D and E) in soleus. The 
mechanical properties of WT and SRP35TG mice are similar (Fig. 1F and Supplementary Table 1) indicating that 
the enhanced running is not due to a gain of function of the excitation-contraction coupling (ECC) mechanism. 
This conclusion is also consistent with the absence of changes in the content of RyR1, Cav1.1 and calsequestrin, 
the main proteins constituting the ECC macromolecular complex (Fig. 1G). On the other hand, SRP-35 over-ex-
pression was accompanied by a significant reduction of the ER(SR) calcium binding protein calreticulin (n = 6, 
p < 0.01, Student’s t test) and of the β1a subunit of the dihydropyridine receptor (n = 6 p < 0.01, Student’s t test). 
SRP35TG muscles also display a 40% increase of glycogen phosphorylase content (GP; Fig. 1G; n = 6 p < 0.01, 
Student’s t test), a key enzyme involved in glucose metabolism activation during muscle contraction25. Because 
of this increase of glycogen phosphorylase we hypothesized that the enhanced running capacity was the result of 
an effect on glucose metabolism.
SRP35TG mice show enhanced glucose metabolism. In vivo glucose clearance was performed by 
the intraperitoneal glucose tolerance test (ipGTT) in young and old (7 and 16 months old, respectively) mice. 
Both age groups of SRP35TG mice showed a two-fold reduction in serum glucose levels 60 min after the glucose 
challenge compared to WT mice (Fig. 2A; n = 8 p < 0.05, Student’s t test). Additionally, there was a significant dif-
ference in glucose clearing kinetics between young and old WT mice at 90 and 120 min. Interestingly in SRP35TG 
mice the glucose clearance curves of young and old mice were similar, with no delay in clearance, suggesting a 
protective effect of SRP-35 over-expression in age-related glucose uptake processes26. The enhanced glucose clear-
ance was not related to altered levels of insulin release, as blood insulin levels were similar in WT and SRP35TG 
mice (Fig. 2B).
Skeletal muscles express two main types of glucose transporters, GLUT1 which is insulin insensitive and 
GLUT4 which is exocytosed onto the plasma membrane in response to insulin. GLUT1 expression levels in total 
muscle homogenates and in the R1 fraction enriched in transverse tubules and plasma membrane27, was similar 
in WT and SRP35TG mice (Supplementary Fig. 2A and B). On the other hand GLUT4 expression in total SR 
and R1 fraction from SRP35TG mice was approximately 50% higher (n = 8  p < 0.01, Student’s t test) compared 
to WT mice (Fig. 2C). The total amount of GLUT4 in the total muscle homogenates from both EDL and soleus 
was unchanged (Fig. 2D), indicating that SRP35TG mice constitutively activate or activate more efficiently the 
signal(s) responsible for GLUT4 translocation onto the plasma membrane and that the increased membrane 
expression of GLUT4 is not caused by enhanced synthesis of this transporter.
The increased running capacity of SRP35TG mice may thus be related to the enhanced capacity of their skel-
etal muscles to remove circulating glucose and store it. We verified this directly (i) by monitoring the capacity of 
isolated muscles to take up glucose and (ii) by monitoring muscle glycogen stores. EDL and soleus muscles were 
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Figure 1. Spontaneous activity, fiber type composition, force measurements and SR protein composition of 
muscles from SRP35TG mice. (A) Spontaneous daily activity of WT (white symbols) and SRP35TG (black 
symbols) mice. Data points from 7 months (left) and 14 months (right) old mice are expressed as mean ± S.D., 
n = 16, ***p < 0.001 Mann–Whitney test. (B) Dark phase speed events recorded from the 15th to 20th day of 
running (mean ± S.D., n = 16). (C) and (D) Fibre type composition Minimal Feret’s diameter determined by 
myosin-heavy chain (MyHC) immunohistochemistry in EDL and soleus muscles of slow (MyHCI) and fast 
(MyHCII) fibres (mean ± S.D., n = 10, *p < 0.05 Student’s t test). (E) Fibre size distribution of EDL and soleus 
muscles from WT and SRP35TG mice (mean ± S.D., n = 10). (F) Mechanical properties of EDL and soleus muscles 
from WT (continuous line, representative trace of experiments carried out in 7 mice) and SRP35TG (dashed line, 
representative trace of experiments carried out in 13 mice) mice. Twitch force stimulated by a 15 V pulse of 0.5ms 
duration. Maximal tetanic force induced by a train of pulses delivered at 200 and 150 Hz for EDL and soleus, 
respectively. (G) Western blot analysis. Thirty-five µg of total SR protein were loaded per lane, separated on 6% 
or 10% SDS/PAGE. Bar histograms represent the mean ± S.D. intensity of the immunoreactive band in SRP35TG 
fraction expressed as % of the intensity of the band in WT mice (n = 6, **p < 0.01 Student’s t test).
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assessed for their capacity to take up 2-deoxy-D-glucose-[3H]) by three different protocols, namely (i) no stim-
ulation, (ii) after challenge with insulin (100 nM for 10 min), and (iii) by a train of action potentials delivered at 
80 Hz for 5 min (Fig. 3A). Under basal conditions, 2-DG-[3H] uptake in muscles from SRP35TG (7 months old) 
male mice was significantly increased compared to WT (Fig. 3A, n = 8; p < 0.05 Student’s t test). This difference in 
glucose uptake was further increased either by insulin treatment or electrical stimulation. Insulin promoted more 
glucose uptake by EDL and soleus muscles of SRP35TG mice (Fig. 3A filled bars, n = 6; p < 0.05 Student’s t test) 
compared to WT littermates (Fig. 3A, empty bars). Muscles from SRP3TG mice accumulated more 2DG-[3H] 
compared to those from WT littermates also after electrical field stimulation (Fig. 3A, n = 6; p < 0.05 unpaired t 
test). Altogether our data demonstrates that both fast and slow muscles isolated from SRP35TG mice show sig-
nificant higher glucose uptake compared to WT littermates, and that the highest increase in glucose uptake was 
observed after insulin stimulation. Glucose taken up by muscles is stored as glycogen, a glucose polymer acting as 
a readily available energy store for muscle activity. Thus the higher glucose uptake by SRP35TG muscles should 
result in larger glycogen stores and this was directly verified by assessing glycogen content by an enzyme-coupled 
assay. Figure 3B shows that the glycogen content in muscles from 7 months old SRP35TG male mice was around 
30% higher compared to that in WT littermates (n = 5; p < 0.05 Student’s t test). Since muscle glycogen content is 
an important factor determining the respiratory exchange rate (RER), we also assessed basic metabolism using a 
CLAMS apparatus. Figure 3C shows cumulative RER of WT (empty circles) and SRP35TG (filled circles) litter-
mates. Each data point represents the average of RER from 7 months old male mice and shows a high degree of 
variability. There were no significant differences in the RER during the dark phase. However, 10 out 23 RER data 
points of the light phase acquired on the last day of measurements were significantly increased in SRP35TG mice 
compared to WT (n = 8; p < 0.05 Student’s t test). These events likely result from an increase of voluntary motor 
activity because we observed a parallel significant increase of the infrared beam breaks data points (Fig. 3D).
Overexpression of SRP-35 affects Akt and AMPK phosphorylation. GLUT4 membrane translo-
cation and glucose uptake in skeletal muscle result from the activation of two major pathways, namely Akt and 
AMP-activated protein kinase (AMPK). Akt activation is linked to the stimulation of the insulin receptor, while 
Figure 2. Glucose uptake and plasma membrane GLUT4 levels are increased in SRP35TG mice. (A) Glucose 
tolerance test (ipGTT) in WT (n = 8) and SRP35TG (n = 8) mice, values are expressed as mean ± S.D. blood 
glucose levels; *p < 0.05; **p < 0.01 Student’s t test. (B) Circulating insulin in WT (n = 8) and SRP35TG 
(n = 8), is expressed as mean ± S.D. pg of insulin measured after glucose injection. Values were not significantly 
different in WT and SRP35TG mice (Student’s t test). (C) GLUT4 content of total SR and R1 fraction (tubule T/
sarcolemma membranes) of skeletal muscles from wild type (wt; n = 8) and SRP3TG (tg; n = 8) mice. Ten µg 
of protein were loaded per lane and separated on 7.5% SDS/PAGE (left); bar histograms of GLUT4 content in 
skeletal muscles from SRP35TG (black bars), normalized to control levels (white bars). Results are expressed 
as mean ± S.D., **p < 0.01; ***p < 0.001 Student’s t test. (D) Western blot of GLUT4 in total homogenate from 
EDL and soleus muscles.
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AMPK activation may occur via multiple mechanisms, including muscle contraction28. To assess the involvement 
of these signaling pathways we performed quantitative western blot analysis and determined the degree of phos-
phorylation of Akt (Ser473 and Thr308) and AMPK (Thr172) in total muscle homogenates. Our results show that 
in muscles from SRP35TG and WT (7 months old) male mice the absolute content of Akt and AMPK in EDL 
and soleus at rest, after electrical stimulation or after the addition of insulin are similar (Fig. 4). Under resting 
conditions in soleus muscles the level of phosphorylation of AMPKThr172 was similar in SRP35TG and WT litter-
mates (Fig. 4A and B), whereas EDLs from SRP35TG show a significant increase (n = 6; p < 0.05, Student’s t test) 
of AMPKT172 phosphorylation compared to WT littermates (Fig. 4A and B). Upon delivery of a repetitive train of 
action potentials the phosphorylation level of AMPKT172 in EDL from SRP35TG mice was further increased from 
resting levels by 49.3% (Fig. 4C and D, p < 0.05 Student’s t test), whereas in soleus the increase was not statistically 
significant (Fig. 4C and D). As to the phosphorylation level of Akt, we found different effects concerning Thr 308 
and Ser 473, namely overexpression of SRP-35 only increases the phosphorylation of Ser 473 in both EDL and 
soleus (results for Aktt308 are not shown). Under resting conditions we observed an increase of the AktS473 phos-
phorylation level in EDL and in soleus, respectively (286.1 ± 132% and 251 ± 137%, mean ± S.D., n = 7, p < 0.05, 
Student’s t test; Fig. 4A and B). Insulin caused a further increase of the resting phosphorylation level of AktS473 in 
EDL and soleus muscles by 58 and 40%, respectively (n = 7, p < 0.05, Student’s t test Fig. 4E and F).
atRA causes AktS473 phosphorylation. Although the exact mechanism by which SRP-35 affects 
Akt phosphorylation is not know, it might be due to the formation of RA resulting from the oxidation of 
all-trans-retinaldehyde, the precursor of RA generated by the up-regulation of the SRP-35 dehydrogenase activity17 
Figure 3. Skeletal muscle glycogen stores and RER in SRP35TG mice. (A) In vitro glucose uptake in EDL and 
soleus muscles from WT and SRP35TG. Three conditions were used: (i) no treatment (Basal; n = 8); (ii) 10 min 
incubation with 100 nM insulin (n = 6), (iii) electrical stimulation with a train of tetani (80 Hz, 300 ms duration) 
delivered at 0.27 Hz for 5 min (n = 6). Data is expressed as mean ± S.D.; *p < 0.05; **p < 0.01 Student’s t test. 
(B) Glycogen content was assessed enzymatically in total homogenates from EDL and soleus muscles. Each 
symbol represents the mean value of both muscles of a single mouse; the median value is represented by the 
horizontal black line; *p < 0.05 Student’s t test. (C) Respiratory exchange ratio (RER) was measured in CLAMS 
cages in WT (n = 8) and SRP35TG (n = 8) mice, fed a standard chow diet. Values are expressed as mean ± S.D.; 
*p < 0.05 Student’s t test. (D) Spontaneous locomotor activity was recorded on X, Y and Z axis, and is expressed 
as mean ± S.D.; n = 8, *p < 0.05 Student’s t test.
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in muscles of SRP35TG mice. We tested this by assessing whether the phosphorylation of AktS473 could be mim-
icked by treatment of muscles from WT mice with pharmacological concentrations of atRA29. Treatment of intact 
EDL and soleus muscles for 30 and 60 min with 10 μM atRA alone did not cause significant changes in the total 
amount of Akt and AMPK protein content (see Supplementary Fig. 2C) and had no effect on the phosphorylation 
status of AktS473, AktT308, and AMPKT172 (Fig. 5A and C). However, atRA may synergize with activators of the Akt 
and AMPK signaling pathways30. Indeed incubation of intact EDL and soleus muscles with atRA in the presence 
of insulin significantly stimulates the phosphorylation of AktS473 by 166.6 ± 24% and 173.6 ± 44%, respectively 
(mean ± S.D., n = 6, p < 0.05, Student’s t test Fig. 5B and D). This increase occurred after 30 min and subse-
quently declined to control values by 60 min. The effect of atRA in the presence of insulin was specific for AktS473 
since we did not observed an increase in the phosphorylation of either AktT308 or AMPKT172 (Fig. 5B and D). 
The fast time course of atRA-induced AktS473 is consistent with a non-genomic action and this was further inves-
tigated by testing the effect of Retinoic acid Receptor α, β and γ inhibitors on AktS473 phosphorylation. Figure 5E 
and F show that phosphorylation of AktS473 induced by atRA in the presence of insulin was abolished by RARα 
and RARγ inhibitors and was insensitive to the RARβ inhibitor
atRA stimulation of Akt phosphorylation is mediated by mTOR complex 2. The higher extent of 
phosphorylation of AktS473 in SRP35TG mice and the in vitro experiments with atRA may result from the activa-
tion of the Rictor/mTORC2 complex31–33. In order to verify this we performed control experiments on muscles 
isolated from muscle specific Rictor knock-out (RImKO) mice34, a mouse model exhibiting down-regulation of 
the mTORC2. EDL and soleus muscles from (3 months old) male RImKO mice were treated with 100 nM insulin 
in the presence or absence of 10 μM atRA. Under these conditions the RImKO mice failed to show significant 
changes in AktS473 phosphorylation (Fig. 6A and B). This effect is specific since under identical experimental con-
ditions phosphorylation of AktS473 occurred in EDL and soleus muscles from WT littermates.
Figure 4. AMPK and Akt phosphorylation levels are increased in muscles from SRP35TG mice. Western 
blots of total homogenates from EDL and soleus muscles. Phosphorylation of AMPKT172 and AktS473 was 
determined under the following experimental conditions. (A) and (B) basal conditions (n = 7). (C) and (D) 
electrical stimulation with a train of tetani (80 Hz, 300 ms duration) delivered at 0.27 Hz for 5 min (n = 6). 
(E) and (F) stimulation with 100 nM insulin (n = 6). Representatives western blots from the three conditions 
are show in panels (A, C and E) and the Bar histograms in panels (B, D and F). Fifty µg of protein from total 
muscle homogenates were loaded per lane, separated on 10% SDS-PAGE and blotted onto nitrocellulose. The 
immunoreactivity to desmin was used to normalize protein loading. Data are presented as % ± S.D. of WT 
values (control); *p < 0.05 Student’s t test.
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PIP3 content in total muscle homogenates from WT and SRP35TG mice. The data obtained with 
RImKO mice demonstrate that atRA synergizes with physiological activators in triggering the enzymatic activity 
of mTORC2. PIP3, a product of the PI3K signaling pathway, is a physiological activator of the kinase activity of 
mTORC235,36. We next measured PIP3 content in EDL and soleus muscles from SRP35TG and WT mice. Figure 6 
(panels C and D) shows that both EDL and soleus muscles from (4 months old) male SRP35TG mice have a 
significant increase of PIP3 content (p < 0.05, Mann-Whitney test). The intracellular level of atRA is influenced 
by the content of Vitamin A in the diet and a reduction of Vitamin A from 14 to 4 IU/g in the mouse chow was 
reported to induce a decrease in atRA content in various mouse tissues37. We assume that at any given intra-
cellular retinol concentration the muscle fibres over-expressing SRP-35 would generate greater amounts of all- 
Figure 5. atRA activates AktS473 phosphorylation in WT EDL and soleus muscles. Fifty µg of protein from 
total muscle homogenates were loaded per lane, separated on 10% SDS-PAGE and blotted onto nitrocellulose. 
AMPKT172, AktS473 and AktT308 phosphorylation levels were measured by western blotting on total homogenates 
from EDL and soleus with specific anti-phospho Ab; P/T = Phosphorylated protein/Total protein. The 
immunoreactivity to desmin was used to normalize gel loading. Data are presented as % ( ± S.D.) of control 
(empty bar); * p < 0.05 Student’s t test. (A) and (C) Skeletal muscles isolated from WT mice were incubated with 
10 μM all-trans-retinoic acid (atRA, bars; n = 6). Left side: representative western blots at 30 min of incubation; 
right side: bar histogram plots. Control values (empty bar) for normalization were obtained by incubating the 
contralateral muscle in the presence of the vehicle solution (DMSO). (B) and (D) EDL and soleus muscles 
incubated with 100 nM insulin plus or minus 10 μM atRA. Left side: representative western blots at 30 min of 
incubation; right side: bar histogram plots (n = 6 *p < 0.05 Student’s t test). Control values (empty bar) for 
normalization were obtained by performing the experiments in the presence of 100 nM insulin plus vehicle 
(DMSO). (E) and (F) EDL muscles were incubated for 30 min in presence of 100 nM insulin, RARα, RARβ 
and RARγ inhibitors plus or minus 10 μM atRA. Control values (empty bar) were obtained in the presence of 
100 nM insulin, plus the RAR inhibitor. Data are presented as mean ± S.D., n = 6, *p < 0.05 Student’s t test.
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Figure 6. SRP-35 and atRA activation of AktS473 is controlled by mTORC2 and the PI3K signaling pathway. (A) 
and (B) Western blot images and bar histograms showing the phosphorylation of Akt and AMPK in EDL and 
soleus muscles from WT (n = 5) and RimKO (n = 5) mice incubated with or without 10 μM atRA in presence 
of 100 nM insulin. Fifty µg of total homogenate protein were loaded per lane, separated on 10% SDS/PAGE and 
blotted onto nitrocellulose. P/T = Phosphorylated protein/Total protein. Anti-desmin immunoreactivity was 
used as loading control (bars represent the mean ± S.D., *p < 0.05 Student’s t test). (C) PIP3 levels from EDL 
muscles isolated from WT and SRP35TG mice fed a standard chow diet (Top panel) and on a low vitamin A diet 
(LVA, 4 I.U/Kg, Bottom panel). Each symbol represents PIP3 values from a single mouse; the median value of 
the data is shown in the box-plot; n.d. = non detectable (muscles from 7 mice) *p < 0.05 Mann-Whitney test. 
(D) PIP3 levels from soleus muscles isolated from WT and SRP35TG mice fed a standard chow diet (Top panel) 
and on a low vitamin A diet (LVA, 4 I.U/Kg, Bottom panel). Each symbol represents PIP3 values from a single 
mouse; the median value of the data is shown in the box-plot; *p < 0.05 Mann -Whitney test. (E) and (F) EDL 
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trans-retinaldehyde the precursor of the irreversible oxidation reaction leading to atRA formation. Thus one 
would expect that if mice were fed a low Vitamin A diet, the SRP35TG mice would generate more atRA compared 
to WT littermates and that the higher atRA levels would be associated with enhanced PI3K activity. We found that 
in (4 months old) male mice that had been fed for two generations with a low vitamin A (4 IU/g) diet, the PIP3 
content in EDL and soleus muscles from WT mice under resting conditions was below the detection limit of the 
method, whereas in EDL muscles from SRP35TG mice the level is approximately 10% of that measured in EDL 
muscles of mice fed a standard chow (Fig. 6C lower panel) and in soleus muscles the PIP3 level is approximately 
70% of that measured in soleus muscles of mice fed a standard chow diet. The higher PI3K activity in muscles 
from SRP35TG kept on a low vitamin A diet should enhance mTORC2/Akt signaling which in turn may lead to 
higher glucose uptake and increased glycogen stores. If this were the case, one would expect better muscle per-
formance. We tested this possibility by investigating the in vitro resistance to fatigue in EDL and Soleus isolated 
from mice kept on a low vitamin A diet for two generations, by measuring the force developed after a train of 
tetanic stimulations of EDL (70 Hz, 300 msec duration) and soleus muscles (50 Hz, 600 msec duration) delivered 
at 0.33 Hz. In the presence of insulin, soleus muscles from SRP35TG showed a significant increase of about 90% 
(Mann-Whitney p < 0.05, n = 5 WT and n = 5 SRP35TG) of the maximal peak tetanic tension at the end of the 
fatigue protocol stimulation (Fig. 6F). Although the absolute peak tetanic tension of EDL from WT and SRP35TG 
mice was much lower compared to that of Soleus, the EDL from SRP35TG mice also showed a significant increase 
of about 100% of the peak tetanic tension at the end of the fatigue protocol (Fig. 6E). The resistance to fatigue is 
likely due, at least in part, to the size of the glycogen stores. Indeed, after the fatigue protocol the glycogen content 
of EDL (Fig. 6G) and soleus (Fig. 6H) muscles from SRP35TG mice kept on a low vitamin A diet was significantly 
higher than that of muscles from WT mice kept on a low vitamin A diet. It should also be pointed out that the 
glycogen stores of EDL and soleus muscles were smaller after the fatigue protocol (Fig. 6G and H) compared to 
the glycogen stores present in unstimulated muscles (Fig. 3B).
Discussion
The present study demonstrates that the skeletal muscle protein SRP-35, a retinol dehydrogenase, is directly 
involved in skeletal muscle metabolism, since its over-expression results in higher glucose uptake and increased 
glycogen storage. In addition, SRP-35 over-expression improves muscle performance in vivo, an effect which 
occurs in the absence of changes in the ECC machinery. We also provide compelling evidence as to the mech-
anism by which SRP-35 leads to the increased glucose uptake in skeletal muscle. In particular we show that 
SRP35TG mice have an up-regulation of the signaling pathway involving AktS473 phosphorylation via activation 
of mTORC2. Pharmacological application of atRA to intact muscles from WT mice mimics the stimulation of 
AktS473 phosphorylation observed in SRP35TG muscles, while inhibitors of the RARα and RARγ nuclear recep-
tors inhibit AktS473 phosphorylation in WT muscle treated with pharmacological concentrations of atRA. On 
the basis of these results we believe that AktS473 phosphorylation in skeletal muscles of SRP35TG mice is linked 
to the enzymatic activity of SRP-35 which produces locally within the muscle, all-trans-retinaldehyde, the pre-
cursor of the irreversible oxidation reaction leading to atRA formation. Altogether these data support a role for 
retinoic acid as the biological mediator of the metabolic response responsible for the enhanced muscle function 
of SRP35TG mice. Figure 7 shows a schematic representation based on the results of the present investigation, of 
the cellular pathways involving SRP-35 and retinoic acid metabolism in skeletal muscle.
Overexpression of SRP-35 and atRA increase AktS473 phosphorylation. Activation of Akt is due to 
phosphorylation of Thr308 and Ser473 by phosphinositide-dependent protein kinase 1 (PDK1) and mTORC2, 
respectively31,33,38. Overexpression of SRP-35 in skeletal muscle selectively increases the phosphorylation of the 
mTORC2-dependent Akt phosphorylation site AktS473 and this occurred both in isolated EDL and soleus muscles 
from SRP35TG in the presence and absence of insulin. This implies that: (i) chronic over-expression of SRP35 in 
skeletal muscle increases the basal AktS473 phosphorylation level, and (ii) the atRA generated by the irreversible 
oxidation all-trans-retinaldehyde, acts as a co-activator of the insulin signaling pathway leading to AktS473 phos-
phorylation. This conclusion is also supported by a separate set of data showing that atRA mimics the effect of 
SRP-35 overexpression. Indeed, treatment of EDL muscles from WT mice with pharmacological concentrations 
of atRA enhanced insulin-induced AktS473 phosphorylation levels. At variance with what was observed in EDL 
muscles isolated from SRP35TG mice however, incubation of EDL from WT mice with atRA in the absence of 
insulin did not result in AktS473 phosphorylation. Our results differ from those showing that in a variety of cells 
types including A549, F9 and HL-60 cells, atRA alone is able to induce Akt phosphorylation39–41. These apparent 
discrepancies may be due to: (i) different experimental models, cofactors and proteins present in the cell culture 
medium;42 (ii) the lack in the EDL from WT mice of the adaptive changes induced by SRP-35 over-expression 
leading to an alteration of the atRA level within a subdomain of the muscle fibre. Nevertheless the present study 
demonstrates that atRA plays a newly identified role in the modulation of cellular functions downstream AktS473 
phosphorylation, including glucose metabolism.
(E) and Soleus (F) muscles from WT (open squares) and SRP35TG (closed squares) mice kept for 2 generations 
under low Vit A diet (LVA), were stimulated in the presence of 100 nM insulin with a train of tetanic stimulation 
(EDL: 70 Hz, 300 ms duration; Soleus 50 Hz, 600 ms duration) delivered at 0.33 Hz. Maximal specific force (mN/
mm2) of the first tetanic contracture is expressed as 100%. Each point represents the mean ± S.D.; n = 5 WT 
and 5 SRP35TG; *p < 0.05 Mann-Whitney. (G) and (H) Glycogen content was assessed enzymatically in total 
homogenates from EDL and Soleus muscles at the end of the fatigue protocol. Each symbol represents the value 
from a single mouse; the median value of the data is shown in the box-plot; *p < 0.05 Mann-Whitney test.
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SRP-35 and atRA activate mTORC2 signaling. Under physiological conditions mTORC2 is the major 
kinase responsible for the phosphorylation of AktS47331. In the presence of DNA damage Akt can also be phospho-
rylated at Ser473 by DNA-dependent protein kinase (DNA-PK)43. Skeletal muscle fibres from SRP35TG mice do 
not show evidence of nuclear damage (not shown) and thus we exclude the possibility that AktS473 phosphoryla-
tion is mediated by DNA-PK. In fact our results on RImKO mice strongly support the participation of mTORC2 
in the SRP-35/atRA signaling pathway. In the present study we show that atRA is unable to reverse the inhibitory 
effect of Rictor ablation on the phosphorylation levels of AktS47 in insulin stimulated skeletal muscles34. This result 
provides unambiguous evidence that mTORC2 activation is a key component of SRP-35/atRA signaling.
atRA: an enhancer of insulin signaling. atRA acts as an enhancer of insulin signaling since it enhances 
AktS473 phosphorylation beyond that caused by the activation of the insulin receptor. The latter is coupled to the 
stimulation of PI3K activity which in turn leads to an increase of PIP3 on the plasma membrane, a crucial step 
for the recruitment of Akt onto the plasma membrane where it is phosphorylated by PDK1 and mTORC2. Akt 
phosphorylation mediates the metabolic effects of insulin, leading to the translocation of GLUT4 onto the plasma 
membrane and stimulating glucose uptake. Both atRA and SRP-35 over-expression synergize with insulin on the 
insulin dependent AktS473 phosphorylation. The RA resulting from the oxidation of all-trans-retinaldehyde, the 
precursor of retinoic acid generated by the up-regulation of the SRP-35 dehydrogenase activity could synergize 
with insulin at different steps of the insulin signaling pathway. The data presented in this study provides insight 
as to one such possible mechanism. In particular, we found that: (i) skeletal muscles from SRP35TG mice have 
a 14 fold increase of the PIP3 content and (ii) manipulation of the myoplasmic concentration of atRA with a 
low Vitamin A diet affects the PIP3 content of skeletal muscle. Previous work has shown that inhibitors of RAR 
nuclear receptors down-regulate PI3K activity, the enzyme responsible for the synthesis of PIP321. On the basis 
of these data and on our own results demonstrating that the AktS473 phosphorylation is prevented by RARα and 
RARγ inhibitors, we believe that the increase of PIP3 content in skeletal muscle from SRP35TG results from a 
non-genomic effect of atRA on PI3K activity21,44. Accumulation of PIP3 in skeletal muscle membranes results in 
the recruitment and activation of mTORC2 kinase leading to the phosphorylation of AktS473.
SRP-35 improves muscle performance by increasing glucose uptake and glycogen store. 
Over-expression of SRP-35 in skeletal muscle leads to a remarkable improvement of the in vivo muscle perfor-
mance, both in young and old (7 and 14 months old, respectively) mice. This effect could be due to a (i) gain of 
function of the ECC mechanism, (ii) fast to slow fibre-type switching, (iii) adaptive metabolic changes, or (iv) 
Figure 7. Schematic representation of the SRP-35 pathway and its effect on glucose metabolism. SRP-35 
transforms retinol to retinal and the latter is converted to retinoic acid. In the presence of insulin, retinoic acid 
activates the Retinoic Acid Receptor α and γ (RARα and RARγ)/ Phosphoinositide 3-kinase (PI3K)/ mTOR 
Complex 2 (mTORC2)/AktS473. Activation of Akt induces the downstream translocation of GLUT4 onto the 
sarcolemma leading to higher glucose uptake by muscles which in turn leads to greater glycogen stores giving 
the skeletal muscle machinery a higher energy source.
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a combination of two or more of these mechanisms. Our results exclude the first possibility because we did not 
observe changes of the mechanical properties of EDL and soleus muscles. Additionally, the enhanced muscle 
performance is not linked to changes in the fibre type composition because there was no evidence of fibre type 
switching in either EDL or soleus. Both type I and type II fibres is soleus muscle from SRP35TG mice undergo 
a 10% increase of the minima Feret’s diameter. The increase of AktS473 phosphorylation may account for this 
small hypertrophy45 of soleus muscles in SRP35TG mice and this is also consistent with the enhanced running 
capacity46. Nevertheless, such a modest hypertrophy cannot fully account for the enhanced running capacity 
observed in SRP35TG mice. In fact our results indicate that the enhanced muscle performance is linked to glu-
cose metabolism. Under basal conditions, skeletal muscles from SRP35TG mice display a specific increment in 
GLUT4 translocation onto the sarcolemma and T tubules and this is accompanied by higher glucose uptake even 
in the absence of insulin. Expression and activation of GLUT4 depends on a variety of stimuli, including RA. 
Indeed treatment of the L6 muscle cell lines with atRA enhanced insulin-stimulated glucose uptake and increased 
GLUT4 expression to plasma membrane24. Activation of the insulin receptor stimulates PI3K activity which ulti-
mately leads to GLUT4 translocation onto plasma membrane by the activation of two parallel signaling cascades: 
Akt phosphorylation and Rho-family small GTPase Rac1. Our results show that in SRP35TG mice the increased 
plasma membrane GLUT4 is linked to an increase of AktS473 phosphorylation. The latter in turn leads to larger 
glycogen stores in skeletal muscle. This adaptive mechanism in SRP35TG mice is accompanied by an increase in 
glycogen phosphorylase (GP), the enzyme initiating the breakdown of glycogen to glucose-1-phosphate during 
prolonged skeletal muscle activity7. We are confident that the longer running distance observed in SRP35TG mice 
is explained by the mechanism described above.
Altogether, our results unravel a novel aspect of RA signaling in skeletal muscle and raise the possibility that 
SRP-35 maybe targeted to affect glucose metabolism in patients with metabolic disorders.
Methods
SRP-35 transgenic mice. The transgenic mouse line (generated in the Transgenic Animal Facility of Basel 
University) was constructed by inserting the mouse SRP-35 cDNA downstream the muscle specific creatine 
kinase promoter to target expression to skeletal muscle. Supplementary Fig. 1 shows a schematic representation 
of the construct used to create the SRP-35 over-expressing mice (SRP35TG) and a representative PCR analysis 
of the genomic DNA from several mouse lines generated after pronuclear injection. Mice were genotyped by 
PCR using genomic DNA, the following primers: 5′- GTAGCTTTTCCTGTCAATTCTGCC-3′(forward) and 
5′- GAGCCCCATGGTGAAGCTT- 3′(reverse) and conditions: GoTaq G2 DNA polymerase (Promega; Madison, 
USA) and the following amplification protocol, 1 cycle at 95 °C for 5 min followed by 38 cycles of annealing (62 °C 
for 30 s), extension (72 °C for 30 s) and denaturation (95 °C for 30 s), followed by a 7 min extension cycle at 72 °C. 
A total of three SRP35TG mouse lines expressing the transgene to different levels were obtained. Since mouse line 
N°5 expressed the highest SRP-35 TG levels, the experiments described in this paper were carried out on this line 
and confirmed in the other two lines.
mTORC2 KO (RImKO) mice. 3 months old male muscle-specific rictor knockout mice (RImKO) were 
obtained from Prof. M. Rüegg’s and Prof. M. Hall’s laboratories34.
Special diet. WT and SRP35TG mice were fed a Low Vitamin A Diet (LVAD; 4 UI/g; Scientific Animal food 
and Engineering) for 2 generations. The mice of the second generation were sacrificed at 4 months of age37.
In vivo and in vitro assessment of muscle function. In vivo muscle function was assessed using the 
voluntary running wheel on 7 and 14 months old male mice as previously described47. For in vitro assessment 
of muscle function, force measurements were assessed using a force transducer (MyoTonic, Heidelberg), and by 
measuring the force generated in response to different protocols including a single twitch (15 V pulses for 0.5 ms 
duration) and tetanic frequency pulses (50, 100 and 150 Hz) in soleus (slow muscle) and (50, 100 and 200 Hz) 
in extensor digitorum longus (EDL, fast muscle). Resistance of muscle to fatigue was also measured in EDL and 
Soleus muscles isolated from WT and SRP35TG mice kept for 2 generations on a low Vitamin A diet. EDL and 
Soleus were incubated in Krebs Ringer containing 100 nM insulin, and stimulated with a train of tetanic stimula-
tion (EDL: 70 Hz, 300 ms duration; Soleus: 600 ms duration, 50 Hz) delivered at 0.33 Hz48
Basic metabolic rate. The metabolic rate of WT and TG (7 months old) male mice was assessed by indirect 
calorimetry using a Comprehensive Lab Animal Monitoring System (Oxymax/CLAMS; Columbus Instruments, 
Columbus, OH, USA). Following an initial 48 h acclimatization, mice were monitored every 17 min for 24 h for a 
complete 12 h active (dark) and 12 h inactive (light) cycle. Oxygen consumption (VO2), CO2 production (VCO2), 
physical activity, heat production and respiratory exchange ratio (RER = V˙CO2 /VO2) were measured during 
72 hours.
Histological examination, changes in muscle fiber type and glycogen content. Calculation of 
the minimal Feret’s diameter, the closest possible distance between the two parallel tangents of an object, was 
determined as previously described49. Images were obtained using an Olympus IX series microscope and ana-
lyzed using the CellP Software. The fiber type composition was assessed by determining the expression of differ-
ent myosin heavy chain isoforms by high resolution gel electrophoresis followed by Coomassie Brilliant blue gel 
staining as described50,51.
Glycogen content was assessed enzymatically on snap frozen EDL and soleus muscles using a 
hexokinase-dependent, kit according to the manufacturer’s instructions (GAHK-20, Sigma-Aldrich; USA). A 
control to measure free glucose levels in the muscle (not related to glycogen stores), was also performed.
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Gel electrophoresis and western blotting. Total homogenates, sarcoplasmic reticulum (SR) and skel-
etal muscle subcellular fractions longitudinal sarcoplasmic reticulum (LSR) and terminal cisternae (TC), were 
prepared as described27. Protein concentration was determined using a kit from BioRad (Bio-Rad, 500–0006) 
using bovine serum albumin as standard; proteins were separated on SDS-PAG gels, transferred onto nitrocellu-
lose membranes and probed with commercially available antibodies. Immunopositive bands were visualized by 
chemiluminescence.
Signaling pathways involved in glucose uptake: Akt and AMPK phosphorylation. Isolated soleus 
muscles from 28 weeks old mice were used to determine the levels of Akt and AMPK phosphorylation. Muscles 
were homogenized in lysis buffer (10% Glycerol, 5% β-mercaptoethanol, 2.3% SDS, 62.5 mM Tris-HCl pH 6.8 
and 6 M urea, supplemented with 1% phosphatase inhibitor cocktails 2 and 3 Sigma Aldrich) at a concentration 
of 10 mg of muscle/ml buffer. Subsequently, 50 µg of protein were separated on a 10% SDS PAG, transferred 
onto nitrocellulose (Amersham), and probed with the following primary antibodies: phospho-AMPK (Thr172), 
AMPK alpha, phospho-Akt (ser 473), phopho-Akt (thr 308) and Akt total from Cell Signaling and Desmin (used 
as housekeeping loading control) from Santa Cruz. The intensity of the immunopositive bands was determined 
using Image J.
Glucose Uptake. Glucose uptake by isolated EDL and soleus muscles was measured in isolated muscles 
incubated for 1 h at room temperature in Krebs-Ringer buffer supplemented with 1 mM glucose, 10 mM sodium 
pyruvate and 0.5% bovine serum albumin. The medium was continuously gassed with 95% O2 and 5% CO2. For 
electrical stimulation, muscles were stimulated with a 300 ms train of action potentials of 0.5 ms duration at a 
frequency of 80 Hz by using a stimulator (Myotronic, Heidelberg Germany); the 300 ms trains of action poten-
tials were delivered for a 5 min at a frequency of 0.27 Hz. For insulin stimulation, muscles were incubated in the 
presence or absence of insulin (100 nM; Novo Nordisk Pharma AG; Bagsværd, Denmark) for 10 min at room tem-
perature. Contralateral non-stimulated muscles were used as controls. Stimulated or control muscles were then 
incubated with 0.375 µCi/ml Deoxy-D-glucose, 2-[1,2–3H (N)] (2-[3H]-DG (Perkin Elmer, Waltham, MA) for an 
additional 20 min at room temperature, flash frozen and stored in liquid nitrogen until ready for use. The amount 
of radioactive glucose taken up by the muscles was assessed by liquid scintillation counting, using a Packard 1900 
TR liquid scintillation analyzer.
Glucose and insulin tolerance tests. For the glucose tolerance test (GTT), following a 6 h fast and start-
ing in the morning, mice were injected intraperitoneally with a glucose-containing solution (1 µg glucose/g of 
body weight). Glucose plasma levels were determined at different time points (0, 15, 30, 60 and 90 min) using a 
glucometer (Freestyle; Abbott Diabetes Care Inc., Alameda, CA; USA). Insulin plasma levels were determined at 
different time points (0, 15 and 30 min) using an insulin ELISA kit (Mercodia; Uppsala, Sweden) following the 
manufacturer’s recommendations.
Effect of all-trans-retinoic acid (atRA). EDL and soleus muscles from 28 weeks old WT mice, were 
cleaned in a Ringer solution continuously gassed with 95% O2 and 5% CO2 at room temperature. The muscles 
were incubated in the presence or absence of 10 µM All-trans-retinoic acid (atRA, dissolved in DMSO; Sigma), 
control muscle were incubated with the vehicle DMSO. After 30 or 60 min of incubation, the muscles were 
washed and stored in liquid N2. In some experiments insulin (100 nM) was also added to the muscles incubated 
with atRA and the controls. The muscles were homogenized; proteins separated by SDS/PAGE and transferred to 
a nitrocellulose membranes. Phosphorylation sites and total protein content of AMPK and AKT were analyzed. 
All experiments were performed under red light illumination.
Effect of Retinoic acid Receptor (RaR) inhibitors. EDL and soleus muscles isolated from WT mice 
were incubated in Ringer’s solution containing one of 3 different RAR inhibitors (RARα, RARβ or RARγ inhibi-
tors), 100 nM insulin and in presence or absence of 10 µM atRA. Muscles from the contralateral leg were taken as 
controls and incubated with the same RAR inhibitor as their counterpart muscles, together with 100 nM insulin 
and DMSO. After a 30 min incubation with the RARα inhibitor Ro 41–5253 (50 nM; Sigma), RARβ inhibitor LE 
135 (220 nM; Sigma) or RARϒ inhibitor Acacetin (30 uM; Sigma), insulin and atRA/DMSO, the muscles were 
flash frozen in liquid N2 and subsequently analysed by western blotting for Akt and AMPK phosphorylation. All 
experiments were performed under red light illumination.
PIP3 measurements. PIP3 levels were measured in muscles of WT and SRP35TG mice fed a standard chow 
or a low vitamin A diet. Freshly isolated EDL muscles were flash frozen in liquid N2 and ground using a pestle and 
mortar. Lipids were extracted from the powdered muscles and PIP3 content was assessed as previously described51 
using the PIP3 Mass ELISA kit (K-2500s, Echelon, USA).
Animal permits. All experiments were conducted according to the Swiss Veterinary Law and institutional 
guidelines and were approved by the Swiss authorities (Kantonal permits 1728 and 2115). All animals were 
housed in a temperature-controlled room with a 12 h light–12 h dark cycle and had free access to food and water.
Statistical analysis. Statistical analysis was performed using the software OriginPro 8.6.0 (OriginLab 
Corporation). Comparisons of two groups were performed using the Student’s t-test, for groups of three or more 
comparisons were made using the ANOVA test followed by the Bonferroni post-hoc test unless otherwise stated. 
Means were considered statistically significant when P values were < 0.05. All figures were created using Adobe 
Photoshop CS6 or R Studio (version 0.99.891 or newer).
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